Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

BACKGROUND: Sepsis and bacterial meningitis are major causes of mortality and morbidity in neonates and infants. Meropenem, a broad-spectrum antibiotic, is not licensed for use in neonates and infants below 3 months of age and sufficient information on its plasma and CSF disposition and dosing in ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Germovsek, Eva, Lutsar, Irja, Kipper, Karin, Karlsson, Mats O, Planche, Tim, Chazallon, Corine, Meyer, Laurence, Trafojer, Ursula M T, Metsvaht, Tuuli, Fournier, Isabelle, Sharland, Mike, Heath, Paul, Standing, Joseph F
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6005047/
https://ncbi.nlm.nih.gov/pubmed/29684147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars